Bulten (BULTEN) Q2 2025 earnings summary

Executive summary

• Q2 performance was stable year-over-year despite an 8.8% sales decline, with strong growth in medical technology and consumer electronics offsetting lower automotive volumes and global uncertainty.

• Strategic review launched to assess organizational structure, operational footprint, and resource allocation, with a shift toward higher-margin, non-automotive markets.

• Disciplined cost management and targeted operational expense reductions led to improved EBIT despite lower net sales.

• Investments made in production capacity, including new facilities and machinery in Sweden and Poland.

• Signed a strategic agreement in Europe with a leading Tier 1 supplier, introducing a vendor managed inventory solution.

Financial highlights

• Net sales for Q2 were SEK 1,337 million, down 8.8% year-over-year, mainly due to lower automotive volumes.

• Adjusted EBIT for Q2 was SEK 69 million, with a 5.2% margin, in line with last year and previous quarter.

• Adjusted earnings per share for Q2 was SEK 1.00; SEK 3.1 for the rolling 12 months.

• Cash flow from operating activities for Q2 was SEK 127 million; cash and cash equivalents at period end were SEK 297 million.

• Net debt at period end was SEK 1,382 million; net debt excluding lease liabilities was SEK 910 million.

Outlook and guidance

• Focus for the rest of 2025 is on high-growth, high-margin markets such as medical technology and consumer electronics, and value-added services.

• Updated strategy and new financial targets are under development, with plans to broaden sales beyond automotive and expand in North America and Asia.

• Q3 is expected to be seasonally weaker due to customer plant shutdowns, but order intake has normalized after a temporary drop from one major customer.

• No specific financial projections or net debt guidance provided.

• A new M&A strategy is being developed to accelerate profitable growth.